KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.
Cancer Lett
; 524: 219-231, 2022 01 01.
Article
in En
| MEDLINE
| ID: mdl-34673129
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endometrial Neoplasms
/
Histone Demethylases
/
TOR Serine-Threonine Kinases
/
MTOR Inhibitors
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Cancer Lett
Year:
2022
Type:
Article
Affiliation country:
United States